A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Recruiting

Phase 3

AzetukalnerA Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

Sponsor:

Xenon Pharmaceuticals Inc.

Code:

NCT06775379

Conditions

Major Depressive Disorder

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Azetukalner

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Xenon Pharmaceuticals Inc. on 2025-03-25.